Clark, P J <br/><br/>
Genetic variation in IL28B: impact on drug development for chronic hepatitis C infection.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Nov 2010 
 - 708-11 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/clpt.2010.185  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--administration & dosage<br/>Drug Administration Schedule<br/>Drug Discovery<br/>Genotype<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferons<br/>Interleukins--genetics<br/>Phenotype<br/>Polymorphism, Single Nucleotide<br/>Translational Research, Biomedical